Comment on

• Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease.

  Monteleone G, Neurath MF, Ardizzone S, Di Sabatino A, Fantini MC, Castiglione F, Scribano ML, Armuzzi A, Caprioli F, Sturniolo GC, Rogai F, Vecchi M, Atreya R, Bossa F, Onali S, Fichera M, Corazza GR, Biancone L, Savarino V, Pica R, Orlando A, Pallone F. Monteleone G, et al. N Engl J Med. 2015 Mar 19;372(12):1104-13. doi: 10.1056/NEJMoa1407250. N Engl J Med. 2015. PMID: 25785968 Clinical Trial.
• Targeting SMAD7 in Crohn's Disease by Mongersen: Therapeutic Revolution Under Way?

  Danese S, Fiorino G, Peyrin-Biroulet L. Danese S, et al. Gastroenterology. 2015 Oct;149(4):1121-3. doi: 10.1053/j.gastro.2015.08.023. Epub 2015 Aug 25. Gastroenterology. 2015. PMID: 26319033 No abstract available.